Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker-guided Reduction of Immunosuppression in Liver Transplant Recipients (BRITRE): A PHASE II TRIAL TO ASSESS THE SAFETY OF BIOMARKER GUIDED IMMUNOSUPPRESSION MINIMIZATION IN LIVER TRANSPLANT RECIPIENTS

NCT07862439 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT07862439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07862439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker-guided Reduction of Immunosuppression in Liver Transplant Recipients (BRITRE): A PHASE II TRIAL TO ASSESS THE SAFETY OF BIOMARKER GUIDED IMMUNOSUPPRESSION MINIMIZATION IN LIVER TRANSPLANT RECIPIENTS
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
January 31, 2031
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver diseases